Creative Bioarray Offers More Than 2,000 Tumor Cells from Human and Animals
Creative Bioarray announced the release of its comprehensive tumor cells from human and animals in order to promote drug research.
United States – December 30, 2022 /MarketersMEDIA/ —
Creative Bioarray, one of the leading biotechnology products and services providers, is dedicated to developing innovative technologies for the cell biology, pharmaceutical, biotechnology, and specialty ingredients markets. With years of experience, Creative Bioarray is committed to supplying the best products and services with global manufacturing, development expertise, and advanced technologies to enhance the overall quality of life. Recently, Creative Bioarray announced the release of its comprehensive tumor cells from human and animals in order to promote drug research.
In cancer research, tumor-derived cell lines are often used as models because they are thought to carry the genomic and epigenomic alterations that occur in tumors. As cancer models, cell lines are cost-effective, easy to use, and amenable to high-throughput screening. Creative Bioarray offers more than 2,000 banked tumor cells from humans and animals. All tumor cells passed comprehensive tests of microbial contamination, virus contamination, and cross-culture contamination.
Creative Bioarray provides human tumor cells from various tissue types with original pathological diagnosis and profiled for key mutations, presents a true characterization of their in vivo state and maintains heterogeneity over multiple passages, enabling researchers to accelerate drug delivery Discovery and process development. The available human tumor cells include astrocytoma/glioblastoma cells, bladder (urinary) tumor cells, brain/nerve tumor cells, breast tumor cells, colorectal tumor cells and esophageal tumor cells.
Animal tumor model systems are used in cancer biology with the goal of studying tumor growth and behavior, as well as cancer therapy, radiology or immunotherapy as potential cancer treatments. Creative Bioarray’s animal tumor cells cover dozens of different animal species, there are hundreds of animal tumor cells and normal tissue cells from various organs and tissues, including bovine tumor cells, cat tumor cells and chicken tumor cells, etc.
Creative Bioarray delivers tumor cell panels by combining validated, well-characterized cell lines with mutational data from the Sanger Institute Catalog of Somatic Mutations in Cancer (COSMIC). Each cell line is STR-validated and mycoplasma-tested and is commonly used in research projects for a variety of small and large molecules. Creative Bioarray introduces tissue-derived tumor cell panels, each commenting on details of known mutations, making tumor cell lines an even more powerful research model and drug discovery tool.
“With significant expertise in cell and genomic research, we provide a variety of high-quality primary cells, tumor cell lines, stem cells, and immortalized cell lines,” said Hannah Cole, the marketing director of Creative Bioarray, she also added, “We are committed to supplying the best products and services with global manufacturing, development expertise, and advanced technologies to enhance the overall quality of life.”
About Creative Bioarray
Creative Bioarray is dedicated to offering customers innovative biotechnology products and services for research use to greatly enhance and drive innovation and standards in science. As a well-recognized industry leader with more than 10 years of experience and in-house expert support, Creative Bioarray has already countenanced research all around the world.
Release ID: 89087330
If you detect any issues, problems, or errors in this press release content, kindly contact email@example.com to notify us. We will respond and rectify the situation in the next 8 hours.